CN102631490B - Traditional Chinese medicine composition capable of improving immunity and resisting fatigue - Google Patents
Traditional Chinese medicine composition capable of improving immunity and resisting fatigue Download PDFInfo
- Publication number
- CN102631490B CN102631490B CN201210121934.1A CN201210121934A CN102631490B CN 102631490 B CN102631490 B CN 102631490B CN 201210121934 A CN201210121934 A CN 201210121934A CN 102631490 B CN102631490 B CN 102631490B
- Authority
- CN
- China
- Prior art keywords
- herba epimedii
- stigma croci
- radix ginseng
- preparation
- resisting fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims description 20
- 241000208340 Araliaceae Species 0.000 claims abstract description 26
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 235000008434 ginseng Nutrition 0.000 claims abstract description 25
- 230000000694 effects Effects 0.000 claims abstract description 12
- 230000036541 health Effects 0.000 claims abstract description 8
- 230000001914 calming effect Effects 0.000 claims abstract description 7
- 210000005036 nerve Anatomy 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 20
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 9
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 9
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 9
- 230000032361 posttranscriptional gene silencing Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000002929 anti-fatigue Effects 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 3
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000003826 tablet Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 229960000796 barbital sodium Drugs 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000517 effect on sleep Effects 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- IYCPMVXIUPYNHI-WPKKLUCLSA-N 3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 IYCPMVXIUPYNHI-WPKKLUCLSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000009613 pulmonary function test Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Abstract
The invention relates to a health care product composition capable of improving the human body immunity and resisting fatigue. The composition comprises the active ingredients such as ginseng, crocus sativus and herba epimedii. The composition has the functions of enhancing the organism immunity, resisting fatigue, calming the nerves and building bodies and has obvious curative effect and mild effects.
Description
Technical field
The present invention relates to a kind of collaborative Chinese medicine composition that improves body immunity, resisting fatigue and tranquillizing and allaying excitement that has.
Technical background
Along with socioeconomic continuous development, the raising day by day of people's living standard, people increase gradually to the degree of keeping a grip on of health, live in now all be, we receive many outside threats easily at everyone health, comprise air pollution, environmental pollution, operating pressure, economic pressures, bacterial virus, improper diet etc.Moreover, because the variation of city work, rhythm of life is easy to make the people to produce confirmed fatigue, i.e. sub-health state, the factor of all these unfavorable health can be made us spiritual usually and can not concentrate, hypomnesis, often indolent and listless, old and feeble ahead of time.Therefore improve autoimmunity, the ability that strengthens the various unfavorable health factors of antagonism is most important.
The health product that are used for enhancing human body immunity power on the market are of a great variety at present, but action effect is uneven.
Summary of the invention
The technical problem to be solved in the present invention is: the purpose of this invention is to provide a kind of enhancing human body immunity power, resisting fatigue and the quelling Chinese medicine composition of calming the nerves.By being main Chinese crude drug with Radix Ginseng, Stigma Croci and Herba Epimedii, by mutual synergistic function, in the hope of improving resistance against diseases, enhance immunity effect, alleviating physical fatigue and the quelling engineering of calming the nerves.
For solving the problems of the technologies described above, the invention provides a kind of collaborative Halth-care composition that improves body immunity, resisting fatigue that has, it is characterized in that described compositions comprises that active component is a kind of to have Synergistic and improve human body immunity of organisms, resisting fatigue and have the quelling of calming the nerves Halth-care composition, is characterized in that described compositions comprises Radix Ginseng, Stigma Croci and Herba Epimedii.In the active component by weight: Radix Ginseng is 1-75 part, and Stigma Croci is 2-65 part, Herba Epimedii 3-65 part.Preferably: Radix Ginseng is 4-50 part, and Stigma Croci is 4-45 part, Herba Epimedii 6-40 part.
Related Radix Ginseng refers to the general name of a kind of herbaceos perennial of the Umbellales Araliaceae Radix Ginseng Panax of family among the present invention, comprises Radix Ginseng Rubra, Radix Ginseng, Radix Panacis Quinquefolii (Radix Panacis Quinquefolii), Radix Glehniae, Radix Codonopsis and Radix Pseudostellariae etc.Radix Ginseng among the present invention comprises through processing and refines back Radix Ginseng extract, various forms in grinding descendant's pure extract powder or Radix Ginseng growth course.
Involved in the present invention to Stigma Croci (claiming Stigma Croci, Stigma Croci again), be the perennial flowers of a kind of Liliales Iridaceae crocus.Stigma Croci among the present invention comprises crocein powder after grinding, obtains Stigma Croci extracts or croceous other processing forms by various processes.
The Herba Epimedii that arrives involved in the present invention can be Berberidaceae plant Herba Epimedii, arrow leaf Herba Epimedii, pubescence Herba Epimedii, or the dried leaves of Herba Epimedii.Herba Epimedii among the present invention is hidden Herba Epimedii powder, icariin, icariin I, the Herba Epimedii A etc. through refining that comprise after grinding.
After the definition of " collaborative improve " can be understood as several medical materials combinations among the present invention, the raising of its drug effect during with respect to independent the use; Drug effect is more lasting; Compositions produces beyond thought effect in new control or healthcare field.
In the component of the present invention, Herba Epimedii mainly act as the enhancing human body immunity function, and blood flow increasing increases coronary flow and anti-hypoxia, calmness, anticonvulsant effect.The Radix Ginseng strongly invigorating primordial QI, promoting the production of body fluid to quench thirst, the Fructus Alpiniae Oxyphyllae of calming the nerves.The effect of dispersing stagnation and relieving accumulation of pathogens, pain relieving, resisting fatigue and resolving stagnation for tranquilization is equalled, mainly played to the Stigma Croci sweet in the mouth.
The inventor finds that by test compositions of the present invention has outside the effect that improves body immunity, resisting fatigue, has stable effect of reposing simultaneously.These single agent are that single agent is incomparable to the beneficial effect of human body effect after by a certain proportion of compositions.
Compositions of the present invention can directly be pulverized or through the active component of the refining compositions as treatment of the extraction of the conventional extractive technique in this area such as decoction and alcohol sedimentation technique or ethanol extract from water precipitation.Described active component can be made various pharmaceutical formulations with pharmaceutically acceptable carrier or excipient composition, as is how granular tablet, granule, capsule, or oral liquid etc.According to using needs, compositions of the present invention also can be processed into slow releasing preparation or quick releasing formulation.Wherein said pharmaceutically acceptable carrier or excipient are selected according to different dosage forms.These used carriers or excipient can determine for the those of ordinary skill of pharmaceutical field.
The preparation method of oral liquid, can but not only be confined to following a kind of, after active component is mixed, decoct with water, decoction liquor is filtered, obtain solution, the gained solution concentration is obtained extractum, then gained extractum be dissolved in 5-10 times of weight of extractum weight concentration in the ethanol water according to weight meter 95%, mix, quantitatively packing obtains oral liquid formulations.
The preparation method of tablet is that the active component mixture is sieved, and behind the auxiliary agent pulverizing commonly used with preparing tablet, abundant mix homogeneously, crosses the 40-80 eye mesh screen, by tabletting the direct machine of dry powder is pressed into tablet.
The preparation technology of capsule preparations can for, the active component mixture is sieved, pulverizing with the commonly used auxiliary agent of preparation tablet, fully behind the mix homogeneously, crossing the 40-80 eye mesh screen, by granulating, drying is irritated capsule after the operations such as granulate, polishing, packing gets product.
The invention has the beneficial effects as follows:
Pharmaceutical composition of the present invention has benefiting QI for strengthening the superficies, improves the immunity of organisms effect, and medicine of the present invention is not warm not dry, effect with invigorating spleen and reinforcing stomach, kidney invigorating and YANG supporting, wet dissipation eliminating impediment, enhancing immunity, resisting fatigue, antiviral, strengthening body, evident in efficacy, action temperature and, have no side effect.This medicine production technology is simple, be easy to take, evident in efficacy, be a kind of desirable raising human immunity, the medicine of resisting fatigue.
Detailed description of the preferred embodiments
Following examples have illustrated the each aspect of the present invention content.They only in order to explanation, not delimit the scope of the invention.
Embodiment 1: contain the preparation that the people participates in the capsule of Stigma Croci, icariin
Radix Ginseng 70 grams, Stigma Croci 15 grams, icariin 25 grams
Above-mentioned Chinese medicine was soaked 40 minutes, it is important that the water surface is higher than raw material, add water total amount and be 8 times of total dose, the back little fire attitude of boiling of boiling is kept liquid level and is higher than raw material Chinese medicine height, decocts 2 hours, cross leaching filtrate, 6 times the water that adds total dose again, the back little fire attitude of boiling of boiling is kept liquid level and is higher than raw material Chinese medicine height, decocted 2 hours, filter to merge twice filtrate, through concentrating under reduced pressure (pressure 0.06MPa, 65 ℃ of temperature) to dried cream, pulverize, through 300 mesh sieves, add the magnesium stearate of gross weight 2%, incapsulate and get final product.
Embodiment 2: contain the preparation that the people participates in the tablet of Stigma Croci, Herba Epimedii
Radix Ginseng 18 grams, Stigma Croci 85 grams, icariin 35 grams
Above-mentioned Chinese crude drug is dried and crushed into coarse powder, with the ethanol of 50-60% be solvent 60-70 ℃ of reflux, extract,, extracting solution is being gone out behind the ethanol, cryoconcentration becomes thick extractum, drying is ground into fine powder, sieves, mixing is granulated, and is pressed into tablet.
Embodiment 3: contain the preparation that the people participates in the capsule of Stigma Croci, Herba Epimedii
Radix Ginseng 18 grams, Stigma Croci 22 grams, icariin 90 grams
Above-mentioned Chinese crude drug is dried and crushed into fine powder, sieves, mixing is packed into firmly softgel shell, makes Chinese medicine composition of the present invention.
Embodiment 4: contain the preparation that the people participates in the oral liquid of Stigma Croci, Herba Epimedii
Radix Ginseng is 75 grams, and Stigma Croci is 65 grams, Herba Epimedii 65 grams
After the said components mixing, decoct with water, decoction liquor is filtered, obtain solution, the gained solution concentration is obtained extractum, gained extractum is dissolved in the concentration of 5-10 times of weight of extractum weight in the ethanol water according to weight meter 95% then, mix, quantitatively packing obtains oral liquid formulations.
Embodiment 5: contain the preparation that the people participates in the capsule of Stigma Croci, Herba Epimedii
Radix Ginseng 4 grams, Stigma Croci 4 grams, icariin 6 grams
Above-mentioned Chinese crude drug is dried and crushed into fine powder, sieves, mixing is packed into firmly softgel shell, makes Chinese medicine composition of the present invention.
Test example 1: the present invention is to improving the clinical efficacy of immune function of human body
The child: immunologic hypofunction, easy catching a cold, average every month more than twice, or suffer from twice above patient of pneumonia in 1 year.
Elderly patients: suffer from multiple chronic disease, be diagnosed as the patient of syndrome of deficiency of lung qi.
2, method of administration and the course for the treatment of:
The oral embodiment of the invention 1, embodiment 2, embodiment 3, embodiment 4, embodiment 5; Contrast: Radix Ginseng; Stigma Croci; Herba Epimedii; Radix Ginseng+Stigma Croci (1: 1); Stigma Croci+icariin (1: 1); Radix Ginseng+Herba Epimedii (1: 1)
Adult: each 3 examples, every day 3 times.
Child below 6 years old: each 1, every day 2-3 time.
Child more than 6 years old: each 2, each 2-3 time.
Above patient was a course for the treatment of with one month all, and it treats 1-3 the course for the treatment of.
3, observational technique:
Carry out blood, urine, just routine test and the heart, pulmonary function test, and observe: heating, aversion to cold, sniffle, pharyngeal symptom and whole body situation and the temperature of having a medical check-up, pharyngeal tonsil, the picture of the tongue pulse condition, therapeutic evaluation is carried out in variations such as fingerprint respectively.
4, therapeutic evaluation
Table one prescription of the present invention improves the clinical observation of immune function of human body
| Compositions | The example number | Obviously improve | Improve | Invalid | Total improvement rate % |
| Embodiment 1 | 120 | 88 | 16 | 16 | 86.7 |
| Embodiment 2 | 105 | 82 | 10 | 13 | 87.6 |
| Embodiment 3 | 121 | 92 | 15 | 14 | 88.4 |
| Embodiment 4 | 118 | 91 | 12 | 15 | 87.3 |
| Embodiment 5 | 125 | 94 | 15 | 16 | 87.2 |
| Radix Ginseng | 45 | 2 | 22 | 21 | 53.3 |
| Stigma Croci | 52 | 4 | 23 | 25 | 51.9 |
| Herba Epimedii | 41 | 6 | 17 | 18 | 56.1 |
| Radix Ginseng+Stigma Croci | 55 | 16 | 24 | 15 | 72.7 |
| Stigma Croci+icariin | 64 | 19 | 25 | 20 | 68.7 |
| Radix Ginseng+Herba Epimedii | 71 | 21 | 26 | 24 | 66.2 |
Drug side effect of the present invention: period in a medicine small number of patients xerostomia, outside the dry stool, all there is not any untoward reaction, drug withdrawal or decrement, mouthfeel, dry stool transference cure.
Test example 2: the present invention is to improving and promote the mice sleep test
Preparation of the present invention (embodiment 1, embodiment 2, embodiment 3, embodiment 4, embodiment 5) is to its acute toxicity, three mutagenesis and improve sleep and detect, draw following result: four preparations are to other SPF level Kunming mouse per os toxicity of both sexes, once irritate the stomach amount and reach 10.0g/kg.bw, animal there is no obvious poisoning symptom in one week, no animal dead, press the acute toxicity grading criteria regulation, this animal subject belongs to nontoxic level.The result is all negative for three project mutagenicity tests (PCEMNR micronucleus test, mouse sperm deformity test, Salmonella reversion test); The feeding trial result showed in 30 days: this tried thing by 0.28,0.70,1.40g/kg.bw dosage (be equivalent to respectively recommend crowd's daily intaking amount 0.014g/kg.bw 20,50,100 times) all do not have obvious influence to the clinical examination of wistar rat, hematology, biochemical, organ weights and indexs such as coefficient and histopathology, do not find that animal subject has tangible toxic action;
Adopt SPF level kunming mice, tried thing continuously and improved sleep effect result of the test in 20 days and show: 1) this is tried the basic, normal, high dosage group of thing and is obviously prolonged the mouse sleep time that the threshold dose pentobarbital sodium is induced, and difference has significance; 2) middle and high dosage group can obviously improve the mice sleep incidence rate that sub-threshold dose penta is induced than appropriate sodium, and difference has significance; 3) middle and high dosage group can obviously shorten the mice sleep incubation period that barbital sodium is induced, and difference has significance; Above result shows: this is tried thing and pentobarbital sodium, barbital sodium have collaborative sleep effect.Illustrate that compositions of the present invention has remarkable facilitation to the sleep of mice.
Test example 3: the present invention is to the influence test of mouse anti-reflecting fatigue
Preparation of the present invention (embodiment 1, embodiment 2, embodiment 3, embodiment 4, embodiment 5) is to mouse anti-reflecting fatigue influence test.90 of mices are divided into six groups at random, press the gastric infusion of dosage shown in the table 2, and every day 1 time, continuous 10 days, normal control group and model group gave the equal-volume distilled water, and volume is 20ml/kg.And in first day on-test.After the last administration 1 hour, animal is put into 15 ± 1 ℃ swimming groove, observe mice and put into water and be sink to the water-bed unable time of floating again for continuing swimming time.The results are shown in Table 2. by table 2 result as seen, compositions of the present invention can obviously prolong mice low temperature and continue swimming time.
Table 2. preparation of the present invention is to the influence of mice swimming time
Result of the test shows, but preparation significant prolongation mice low temperature of the present invention continues swimming time.
Claims (7)
1. one kind has collaborative human body immunity of organisms, antifatigue effect and the quelling Halth-care composition of calming the nerves of improving, it is characterized in that its effective ingredient is Radix Ginseng, Stigma Croci and Herba Epimedii, and form according to the raw material of following weight parts: Radix Ginseng is 4-50 part, Stigma Croci is 4-45 part, Herba Epimedii 6-40 part.
2. compositions according to claim 1, it is characterized in that in total active component, by weight: Radix Ginseng is 3-25 part, Stigma Croci is 2-20 part, Herba Epimedii 3-20 part.
3. compositions according to claim 1 is characterized in that Herba Epimedii is icariin.
4. compositions according to claim 1 is characterized in that described compositions is the preparation of peroral dosage form.
5. the described compositions of claim 1 has the purposes that improves in the immunity health medicine in preparation.
6. the described compositions of claim 1 has purposes in the anti-fatigue health-caring medicine in preparation.
7. the described compositions of claim 1 has purposes in the calm health medicine of calming the nerves in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210121934.1A CN102631490B (en) | 2012-04-24 | 2012-04-24 | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210121934.1A CN102631490B (en) | 2012-04-24 | 2012-04-24 | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102631490A CN102631490A (en) | 2012-08-15 |
| CN102631490B true CN102631490B (en) | 2013-08-14 |
Family
ID=46616170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210121934.1A Active CN102631490B (en) | 2012-04-24 | 2012-04-24 | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102631490B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070961B (en) * | 2013-02-04 | 2014-12-17 | 山西振东家庭健康护理用品有限公司 | Chinese medicinal anti-bacteria health care foot-massage solution and preparation method thereof |
| CN104224885A (en) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | Traditional Chinese medicine composition for relieving physical fatigue |
-
2012
- 2012-04-24 CN CN201210121934.1A patent/CN102631490B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102631490A (en) | 2012-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103039970B (en) | A kind of active component and preparation method thereof of nutrient and healthcare products with resist oxygen lack, antifatigue | |
| CN104435749A (en) | Dendrobium officinale compound preparation as well as preparation method and application of dendrobium officinale compound preparation | |
| CN106237075A (en) | A kind of have resisting fatigue and promote the food of attention effect, health product or pharmaceutical composition and its production and use | |
| CN104288644A (en) | Pharmaceutical composition for treating spleen deficiency and preparation method thereof | |
| CN102631494B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN101085039B (en) | Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method | |
| CN104055935A (en) | Traditional Chinese medicine composition for improving immunity in synergetic mode | |
| CN101129485A (en) | Pyrrosia lingua farw Tonglin beverage | |
| CN102631490B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN101347543A (en) | Chinese medicine compound and preparation method thereof | |
| CN103893593B (en) | Pharmaceutical composition with effects of clearing away heat and toxic materials, resisting inflammations and boosting immunity | |
| CN102631498B (en) | Chinese medicinal composition | |
| CN102631492B (en) | Chinese medicinal composition for improving immunity and resisting fatigue | |
| CN111298020B (en) | Traditional Chinese medicine composition with anti-fatigue effect and preparation method and application thereof | |
| CN102631488B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631506B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631486B (en) | Health care composition | |
| CN102631487B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631496B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102120000B (en) | Composition of effective parts of traditional Chinese medicine preparation for resisting Coxsackie virus B and preparation method thereof | |
| CN102631489B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631493B (en) | Health care composition | |
| CN102631394B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631389A (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631393B (en) | Health care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220923 Address after: 224100 6, Jinfeng South Street, Dafeng District, Yancheng City, Jiangsu. Patentee after: Dafeng District Productivity Promotion Center, Yancheng City Address before: Ji Hongjinzhuan, Development Department, Jiangsu Huifeng Agrochemical Co., Ltd., South Head of Wanggang Zha, Dafeng City, Yancheng City, Jiangsu Province, 224100 Patentee before: Yang Cuihong |
|
| TR01 | Transfer of patent right | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: JIANGSU HUIFENG BIO AGRICULTURE Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980042603 Denomination of invention: Traditional Chinese medicine composition for enhancing immunity and anti fatigue Granted publication date: 20130814 License type: Common License Record date: 20230926 |
|
| EE01 | Entry into force of recordation of patent licensing contract | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120815 Assignee: DAFENG HEGNO PHARMACEUTICALS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045165 Denomination of invention: Traditional Chinese medicine composition for enhancing immunity and anti fatigue Granted publication date: 20130814 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: YANCHENG DESANO PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045163 Denomination of invention: Traditional Chinese medicine composition for enhancing immunity and anti fatigue Granted publication date: 20130814 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: JIANGSU BROTHER VITAMINS Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045158 Denomination of invention: Traditional Chinese medicine composition for enhancing immunity and anti fatigue Granted publication date: 20130814 License type: Common License Record date: 20231102 Application publication date: 20120815 Assignee: JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL Co.,Ltd. Assignor: Dafeng District Productivity Promotion Center, Yancheng City Contract record no.: X2023980045154 Denomination of invention: Traditional Chinese medicine composition for enhancing immunity and anti fatigue Granted publication date: 20130814 License type: Common License Record date: 20231102 |
|
| EE01 | Entry into force of recordation of patent licensing contract |